Aller au contenu principal

 Articles scientifiques

Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.

Auteurs : Caparica R, Bruzzone M, Hachem GE, Ceppi M, Lambertini M, Glasberg J, de Azambuja E, Van Laethem JL, Hendlisz A
Année : 2020
Journal : Crit Rev Oncol Hematol
Volume : 149
Pages : 102940

Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.

Auteurs : Franzoi MA, Vandeputte C, Eiger D, Caparica R, Brandão M, de Angelis C, Hendlisz A, Awada A, Piccart-Gebhart M, de Azambuja E
Année : 2020
Journal : Breast Cancer Res Treat
Volume : 181
Pages : 199-209

Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report.

Auteurs : Herchuelz M, Marin G, Derijckere ID, Vouche M, Delatte P, Donckier V, Liberale G, Hendlisz A, Artigas C, Bourgeois P, Flamen P
Année : 2020
Journal : Radiol Case Rep
Volume : 15
Pages : 548-551

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.

Auteurs : Craciun L, de Wind R, Demetter P, Willard-Gallo K, Lucidi V, Bohlok A, Michiels S, Bouazza F, Vouche M, Tancredi I, Verset G, Garaud S, Naveaux C, Gomez Galdon M, Hendlisz A, Derijckere ID, Flamen P, Larsimont D, Donckier V
Année : 2020
Journal : BMC Cancer
Volume : 20
Pages : 135

Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18 F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial.

Auteurs : Camera S, Akin Telli T, Woff E, Vandeputte C, Kehagias P, Guiot T, Critchi G, Wissam Y, Bregni G, Trevisi E, Pretta A, Senti C, Leduc S, Gkolfakis P, Hoerner F, Rothé F, Sclafani F, Flamen P, Deleporte A, Hendlisz A
Année : 2020
Journal : Cancers (Basel)
Volume : 12

Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis

Auteurs : El Asmar A, Bendavides M, Moreau M, Hendlisz A, Deleporte A, Khalife M, Donckier V, Liberale G
Année : 2020
Journal : World J Surg Oncol
Volume : -
Pages : -

Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.

Auteurs : El Asmar A, Bendavides M, Moreau M, Hendlisz A, Deleporte A, Khalife M, Donckier V, Liberale G
Année : 2020
Journal : World J Surg Oncol
Volume : 18
Pages : 311

Current practice in approaching controversial diagnostic and therapeutic topics in gastroenteropancreatic neuroendocrine neoplasm management. Belgian multidisciplinary expert discussion based on a modified Delphi method.

Auteurs : Cuyle PJ, Geboes K, Carton S, Casneuf V, Decaestecker J, De Man M, Demolin G, Deroose CM, De Vleeschouwer C, Flamen P, Hendlisz A, Hoorens A, Janssens J, Karfis I, Lybaert W, Machiels G, Monsaert E, Sinapi I, van Cutsem E, Vandamme T, Borbath I, Verslype C
Année : 2020
Journal : Acta Gastroenterol Belg
Volume : 83
Pages : 643-653

Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy.

Auteurs : Caparica R, Amorim L, Amaral P, Uratani L, Muniz D, Hendlisz A, de Azambuja E, Glasberg J, Takahashi TK, Filho EA, Canellas R, Saragiotto D, Sabbaga J, Mak M
Année : 2020
Journal : BMJ Support Palliat Care

Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients.

Auteurs : Bohlok A, Vermeulen P, Leduc S, Latacz E, Botzenhart L, Richard F, De Schepper M, Geukens T, Lucidi V, Ignatiadis M, Aftimos P, Sotiriou C, Piccart-Gebhart M, Hendlisz A, Van Laere S, Dirix L, Noël JC, Biganzoli E, Larsimont D, Desmedt C, Donckier V
Année : 2020
Journal : NPJ Breast Cancer
Volume : 6
Pages : 64

Fat density is a novel prognostic marker in patients with esophageal cancer.

Auteurs : Anciaux M, Van Gossum A, Wenglinski C, Ameye L, Guiot T, Flamen P, Demetter P, Deleporte A, Sclafani F, Donckier V, Hendlisz A, Vandeputte C
Année : 2020
Journal : Clin Nutr ESPEN
Volume : 39
Pages : 124-130

Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer

Auteurs : Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P
Année : 2019
Journal : J Nucl Med
Volume : 60
Pages : 178-184

The metabolic clinical risk score as a new prognostic model for surgical decision-making in patients with colorectal liver metastases.

Auteurs : Duran Derijckere I, Levillain H, Bohlok A, Mathey C, Nezri J, Muteganya R, Trotta N, Lucidi V, Bouazza F, Germanova D, Van Simaeys G, Goldman S, Hendlisz A, Flamen P, Donckier V
Année : 2019
Journal : J Surg Oncol

FOLFIRI as second-line treatment of metastatic biliary tract cancer patients.

Auteurs : Caparica R, Lengelé A, Bekolo W, Hendlisz A
Année : 2019
Journal : Autops Case Rep
Volume : 9
Pages : e2019087

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study.

Auteurs : Levillain H, Duran Derijckere I, Ameye L, Guiot T, Braat A, Meyer C, Vanderlinden B, Reynaert N, Hendlisz A, Lam M, Deroose CM, Ahmadzadehfar H, Flamen P
Année : 2019
Journal : Eur J Nucl Med Mol Imaging
Volume : 46
Pages : 2270-2279

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.

Auteurs : Charette N, Vandeputte C, Ameye L, Bogaert CV, Krygier J, Guiot T, Deleporte A, Delaunoit T, Geboes K, Van Laethem JL, Peeters M, Demolin G, Holbrechts S, Flamen P, Paesmans M, Hendlisz A
Année : 2019
Journal : BMC Cancer
Volume : 19
Pages : 134

Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies.

Auteurs : Springuel L, Lonez C, Alexandre B, van Cutsem E, Machiels JH, Van den Eynde M, Prenen H, Hendlisz A, Shaza L, Carrasco J, Canon JL, Opyrchal M, Odunsi K, Rottey S, Gilham DE, Flament A, Lehmann FF
Année : 2019
Journal : BioDrugs
Volume : 33
Pages : 515-537

The close interrelation between colorectal cancer, infection and microbiota.

Auteurs : Massaut E, Hendlisz A, Klastersky J
Année : 2019
Journal : Curr Opin Oncol
Volume : 31
Pages : 362-367

Editorial: Adjuvant chemotherapy for rectal cancer: playing the devil's advocate.

Auteurs : Sclafani F, Hendlisz A
Année : 2019
Journal : Curr Opin Oncol
Volume : 31
Pages : 336-338

PRODIGE 7 should be interpreted with caution.

Auteurs : Liberale G, Ameye L, Hendlisz A
Année : 2019
Journal : Acta Chir Belg
Volume : 119
Pages : 263-266